Introduction
Only about half of patients with multidrug-resistant TB are cured. Unitaid is investing in developing treatments that are simpler, shorter and less toxic.
TB is a top priority for Unitaid, including this most recent effort to speed access to better, shorter, and more effective MDR-TB treatments. Image: Graeme Williams / Unitaid
